A5115600069- Liver Disease Diagnosis and Treatment
- Hepatitis C virus research
- Metabolism and Genetic Disorders
- Liver Disease and Transplantation
- Hepatitis B Virus Studies
- Systemic Lupus Erythematosus Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diet and metabolism studies
- Immune Cell Function and Interaction
- Lipoproteins and Cardiovascular Health
- Folate and B Vitamins Research
- Nutrition and Health in Aging
- Mitochondrial Function and Pathology
- Liver Diseases and Immunity
- Cancer Immunotherapy and Biomarkers
- Genetics, Aging, and Longevity in Model Organisms
- Diabetes Management and Research
- Nutritional Studies and Diet
- Stroke Rehabilitation and Recovery
- Hepatocellular Carcinoma Treatment and Prognosis
- T-cell and B-cell Immunology
- Methemoglobinemia and Tumor Lysis Syndrome
- Frailty in Older Adults
- Metabolomics and Mass Spectrometry Studies
- Lipid metabolism and disorders
University of Catania
2011-2023
Ospedale Cannizzaro
2006-2015
Minia University
2011
Weatherford College
2009
Doctors Hospital
2006
Regione Siciliana
2000
Institute of Neurological Sciences
1996-1997
Centre Hospitalier Universitaire d'Angers
1996
Nonalcoholic steatohepatitis (NASH) is a known metabolic disorder of the liver. No treatment has been conclusively shown to improve NASH or prevent disease progression. The function L-carnitine modulate lipid profile, glucose metabolism, oxidative stress, and inflammatory responses shown. aim this study was evaluate effects L-carnitine's supplementation on regression NASH.In patients with control subjects, we randomly dispensed one 1-g tablet after breakfast plus diet 1 g dinner for 24 weeks...
Background Hepatic encephalopathy (HE) is a reversible neuropsychiatric syndrome in patients with liver disease. It was suggested that Bifidobacterium+fructo-oligosaccharides (FOS) may decrease blood and brain ammonia levels. Aim The study conducted to compare the efficacy of Bifidobacterium+FOS lactulose HE. Methods One hundred twenty-five (35 hepatitis B virus infected, 70 C infected 20 cryptogenetic cirrhosis) were enrolled study. Patients randomized either treatment for 60 days...
IFN alpha treatment is able to produce dose-related side effects, such as depression, in the central nervous system. We assessed effects on depression of four different types (recombinant 2a, recombinant 2b, lymphoblastoid alpha, leukocyte alpha), administered at same doses homogeneous groups chronic hepatitis C patients (96 patients; 24 for each group). A group 18 untreated was considered a control group. Depression measured using Zung’s self-rating scale (SDS scale) before starting therapy...
Abstract Inflammation has been reported to be involved in the pathogenesis of cerebrovascular dementias (CvDs). This study investigated involvement Chitotriosidase (ChT), a chinolitic enzyme mainly produced by activated macrophages, pathophysiology Alzheimer's disease (AD) and ischemic CvD. In addition, levels interleukin (IL)‐16, IL‐18, transforming growth factor (TGF) ‐β1 superoxide anion (O 2 – ) were determined evaluate relationship between ChT levels, these cytokines oxidative stress...